Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Depreciation & Amortization (CF) (2015 - 2026)

Cellectis (CLLS) posted quarterly Depreciation & Amortization (CF) of $4.5 million for Q1 2026, down 8.03% year-over-year from $4.9 million in Q1 2025, and down 9.5% quarter-over-quarter from $5.0 million in Q3 2025.

Analysis

Cellectis (CLLS) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Cellectis' Depreciation & Amortization (CF) history runs 12 years deep, the most recent figure standing at $4.5 million for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 8.03% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $14.6 million (up 1.28% YoY), while the FY2016 annual figure was $2.2 million, up 14.11% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $4.5 million, down from $5.0 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $5.0 million in Q2 2025, with the low at $4.3 million in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $4.6 million (2024), against an average of $4.7 million.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 32.11% in 2022, then decreased 9.08% in 2023.
  • Cellectis' Depreciation & Amortization (CF) stood at $4.3 million in 2022, then gained by 3.72% to $4.5 million in 2023, then gained by 5.69% to $4.7 million in 2024, then climbed by 6.17% to $5.0 million in 2025, then decreased by 9.5% to $4.5 million in 2026.
  • Business Quant data shows CLLS's Depreciation & Amortization (CF) at $4.5 million in Q1 2026, $5.0 million in Q3 2025, and $5.0 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Cellectis 321.90 Mn 155.05 Mn - 4.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.41 Mn
Mar 31, 2026 4.54 Mn
Dec 31, 2025 5.10 Mn
Sep 30, 2025 5.01 Mn
Jun 30, 2025 5.02 Mn
Mar 31, 2025 4.93 Mn
Dec 31, 2024 5.83 Mn
Sep 30, 2024 4.72 Mn
Jun 30, 2024 4.73 Mn
Mar 31, 2024 4.57 Mn
Dec 31, 2023 5.18 Mn
Sep 30, 2023 4.47 Mn
Jun 30, 2023 4.42 Mn
Mar 31, 2023 4.46 Mn
Dec 31, 2022 4.73 Mn
Sep 30, 2022 4.31 Mn
Jun 30, 2022 5.11 Mn
Mar 31, 2022 4.90 Mn
Dec 31, 2021 2.62 Mn
Sep 30, 2021 4.37 Mn